What is the latest SYNGENE stock price?
The latest stored price for SYNGENE is Rs 441.20 as of 2026-11-16.
SYNGENE INTERNATIONAL LTD is a small-cap stock in Healthcare. This Gimli page shows the latest available SYNGENE price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.
The latest stored price for SYNGENE is Rs 441.20 as of 2026-11-16.
SYNGENE is above 50DMA, above 200DMA. The latest 50DMA is 388.53 and the latest 200DMA is 420.74.
SYNGENE has PE 95.25, ROE +3.89%, and ROCE +5.58% in Gimli's latest available snapshot.
SYNGENE has returned +14.27% over 1 month, +9.90% over 3 months, and -32.58% over 12 months in the latest stored data.
No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.
| Period | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-09-30 | 832.70 cr | 168.70 cr | 32.20 cr | 0.80 |
| 2026-06-30 | 736.00 cr | 102.60 cr | -9.00 cr | -0.22 |
| 2026-03-31 | 1,036.50 cr | 319.60 cr | 147.90 cr | 3.68 |
| 2025-12-31 | 917.10 cr | 154.00 cr | 15.00 cr | 0.37 |
| 2025-09-30 | 926.00 cr | 214.90 cr | 67.10 cr | nan |
| 2025-06-30 | 874.50 cr | 224.10 cr | 86.70 cr | 2.16 |
| 2025-03-31 | 1,018.00 cr | 362.50 cr | 183.30 cr | 4.56 |
| 2024-12-31 | 943.70 cr | 301.90 cr | 131.10 cr | 3.27 |
| Year | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-03-31 | 3,738.70 cr | 912.60 cr | 316.70 cr | 7.87 |
| 2025-03-31 | 3,642.40 cr | 1,145.60 cr | 496.20 cr | 12.35 |
| 2024-03-31 | 3,369.50 cr | 1,091.80 cr | 510.00 cr | 12.71 |
| 2023-03-31 | 3,080.20 cr | 994.60 cr | 464.40 cr | 11.59 |
| 2022-03-31 | 2,709.00 cr | 811.60 cr | 393.80 cr | 9.94 |
| Period | Assets | Cash | Debt | Equity |
|---|---|---|---|---|
| 2026-03-31 | 7,054.70 cr | 228.60 cr | 458.40 cr | 4,839.10 cr |
| 2025-03-31 | 6,795.90 cr | 366.90 cr | 577.90 cr | 4,726.80 cr |
| 2024-03-31 | 6,151.60 cr | 85.60 cr | 555.20 cr | 4,257.70 cr |
| 2023-03-31 | 5,831.00 cr | 87.00 cr | 815.20 cr | 3,618.00 cr |
| 2022-03-31 | 5,563.80 cr | 261.00 cr | 1,021.60 cr | 3,297.60 cr |
| Period | OCF | FCF | Cash change |
|---|---|---|---|
| 2026-03-31 | 915.20 cr | 547.00 cr | n/a |
| 2025-03-31 | 1,167.60 cr | 397.50 cr | n/a |
| 2024-03-31 | 1,042.10 cr | 531.30 cr | n/a |
| 2023-03-31 | 823.50 cr | 305.20 cr | n/a |
| 2022-03-31 | 580.60 cr | 105.10 cr | n/a |
| Period | Promoter | FII/FPI | DII | MF | Retail | Pledge |
|---|---|---|---|---|---|---|
| 2026-09-30 | +52.59% | +10.14% | +29.30% | +27.10% | +7.56% | +0.00% |
| 2026-06-30 | +52.59% | +11.82% | +28.02% | +25.78% | +7.14% | +0.00% |
| 2026-03-31 | +52.68% | +13.90% | +26.44% | +24.18% | +6.69% | +0.00% |
| 2025-12-31 | +52.68% | +14.96% | +25.84% | +22.71% | +6.22% | +0.00% |
| 2025-09-30 | +52.68% | +16.31% | +24.62% | +21.22% | +6.08% | +0.00% |
| 2025-06-30 | +52.68% | +16.50% | +24.05% | +20.70% | +6.45% | +0.00% |
| 2025-03-31 | +52.74% | +19.47% | +21.50% | +17.86% | +6.00% | +0.00% |
| 2024-12-31 | +52.74% | +20.64% | +19.53% | +15.40% | +6.80% | +0.00% |
| 2024-09-30 | +54.72% | +20.72% | +17.48% | +13.58% | +6.74% | +0.00% |
| 2024-06-30 | +54.72% | +20.63% | +16.80% | +13.63% | +7.42% | +0.00% |
| 2024-03-31 | +54.79% | +20.92% | +15.80% | +12.59% | +8.17% | +0.00% |
| 2023-12-31 | +54.79% | +21.20% | +14.64% | +11.93% | +9.05% | +0.00% |
| 2023-09-30 | +54.79% | +23.55% | +11.71% | +9.09% | +9.46% | +0.00% |
| 2023-06-30 | +54.80% | +23.19% | +11.20% | +8.58% | +10.21% | +0.00% |
| 2023-03-31 | +54.88% | +23.30% | +10.73% | +8.35% | +10.63% | +0.00% |
| 2022-12-31 | +64.86% | +16.86% | +7.04% | +5.01% | +10.77% | +0.00% |
| 2022-09-30 | +64.86% | +16.79% | +6.77% | +4.78% | +11.09% | +0.00% |
| 2022-06-30 | +70.29% | +0.00% | +18.33% | n/a | n/a | +0.00% |
| 2022-03-31 | +70.41% | +0.00% | +18.10% | n/a | n/a | +0.00% |
| 2021-12-31 | +70.41% | +0.00% | +18.25% | n/a | n/a | +0.00% |
| Symbol | Name | Mcap | PE | ROE | 1Y |
|---|---|---|---|---|---|
| SUNPHARMA | SUN PHARMACEUTICAL IND L | 448,075.81 cr | 40.781879 | +14.03% | +6.28% |
| DIVISLAB | DIVI S LABORATORIES LTD | 294,139.21 cr | 87.463339 | +21.13% | +70.16% |
| TORNTPHARM | TORRENT PHARMACEUTICALS L | 178,438.17 cr | 85.011038 | +16.67% | +22.43% |
| APOLLOHOSP | APOLLO HOSPITALS ENTER. L | 126,113.56 cr | 53.952325 | +24.95% | +18.20% |
| LAURUSLABS | LAURUS LABS LIMITED | 119,848.17 cr | 89.960566 | +26.71% | +122.22% |
| ZYDUSLIFE | ZYDUS LIFESCIENCES LTD | 118,902.46 cr | 27.636309 | +15.44% | +26.21% |
| DRREDDY | DR. REDDY S LABORATORIES | 114,723.24 cr | 41.579949 | +7.80% | +10.59% |
| CIPLA | CIPLA LTD | 112,647.78 cr | 39.472630 | +8.80% | -8.98% |
Data snapshot: 2026-11-16. Not investment advice.